Skip to content

Study for the mechanism of ''166'' yoghurt compound preparation in the treatment of functional slow transit constipation

Study for the mechanism of ''166'' yoghurt compound preparation in the treatment of functional slow transit constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032545
Enrollment
Unknown
Registered
2020-05-02
Start date
2019-05-09
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation

Interventions

Group 1:In the first stage, one of the yogurt preparations was taken once a day for 4 weeks, and then stopped for 4 weeks. In the second stage, another yogurt preparation was taken once a day, 1 bottl
Group 2:In the first stage, one of the yogurt preparations was taken once a day for 4 weeks, and then stopped for 4 weeks. In the second stage, another yogurt preparation was taken once a day, 1 bottl

Sponsors

Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. according to Rome IV standard, constipation caused by intestinal and systemic organic factors, drugs and other causes need to be excluded and meet the following criteria: subject must meets the following two or more symptoms: (1) at least 25% of the time defecation is strenuous; (2) at least 25% of the time is massive or hard defecation; (3) at least 25% of the time defecation has a sense of incomplete defecation; (4) at least 25% of the time defecation has a sense of anorectal obstruction or obstruction; (5) at least 25% of the time defecation requires manual assistance (such as defecation with finger assistance, pelvic floor); (6) spontaneous defecation less than 3 times a week; 2. few loose stools occur when laxatives are not used; 3. do not meet the diagnostic criteria of IBS-C; 4. the age was between 18 and 60 years old, the above symptoms appeared for at least 6 months, and the symptoms in the past 3 months met the above diagnostic criteria; 5. two weeks before entering the group, there were no drugs that could cause constipation, no prokinetic drugs, microecological agents, permeability drugs and other drugs to treat constipation, antibiotics and other drugs were not used; 6. the patients themselves and their family members had informed consent, voluntarily participated in the clinical trial study, had good compliance, and voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. those who did not meet the above diagnostic criteria had poor compliance and did not sign an informed consent form to participate in the trial and study voluntarily; 2. patients with severe heart, brain, liver and kidney dysfunction, uremic coma, ketoacidosis, hypoglycemia, anemia, malnutrition, hematopoietic and systemic immune system diseases, infectious diseases, nervous system diseases and so on; 3. patients should not be diagnosed as functional constipation if they meet the diagnostic criteria of opioid-induced constipation, but clinicians should pay attention to the overlap between functional constipation and opioid-induced constipation; 4. patients with organic lesions such as tumors in the intestine, as well as inflammation, intestinal stenosis or obstruction caused by surgery should be excluded; 5. special groups such as pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
scale;serum immunological indexes;gut microbiota;

Secondary

MeasureTime frame
Blood routine examination;liver function;renal function;urinalysis;routine stool test;12-leads electrocardiogram;

Countries

China

Contacts

Public ContactYongli Li

Henan Provincial People's Hospital

shyliyongli@126.com+86 13633812936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026